Document is current
Any future updates will be listed below
-
Authors
Liu, Zhanju https://orcid.org/0000-0002-0326-543X
Liu, Ruize
Gao, Han
Jung, Seulgi https://orcid.org/0000-0002-7264-4310
Gao, Xiang
Sun, Ruicong
Liu, Xiaoming
Kim, Yongjae
Lee, Ho-Su
Kawai, Yosuke https://orcid.org/0000-0003-0666-1224
Nagasaki, Masao https://orcid.org/0000-0002-4292-8785
Umeno, Junji https://orcid.org/0000-0002-5253-5600
Tokunaga, Katsushi https://orcid.org/0000-0001-5501-0503
Kinouchi, Yoshitaka
Masamune, Atsushi https://orcid.org/0000-0001-7184-7282
Shi, Wenzhao
Shen, Chengguo
Guo, Zhenglin
Yuan, Kai https://orcid.org/0000-0002-8460-6581
,
,
Abreu, Maria
Achkar, Jean-Paul
Andersen, Vibeke
Bernstein, Charles
Brant, Steven R.
Bujanda, Luis
Ng, Siew Chien
Denson, Lee A.
Duerr, Richard H.
Ferguson, Lynnette R.
Franchimont, Denis
Franke, Andre
Gearry, Richard
Hakonarson, Hakon
Halfvarson, Jonas
Heller, Caren
Julià, Antonio
Kelsen, Judith
Khalili, Hamed
Kugathasan, Subramaniam
Kupcinskas, Juozas
Latiano, Anna
Louis, Edouard
Malekzadeh, Reza
McCauley, Jacob L.
Moran, Christopher
Okou, David
Orchard, Tim
Palotie, Aarno
Parkes, Miles
Pekow, Joel
Potočnik, Uroš
Radford-Smith, Graham
Rioux, John D.
Rogler, Gerhard
Sands, Bruce
Silverberg, Mark
Sokol, Harry
Vermeire, Séverine
Weersma, Rinse K.
Xavier, Ramnik J.
,
Hu, Naizhong
Cao, Qian
Wang, Yufang
Miao, Yinglei
Zhang, Hongjie
Lv, Xiaoping
Gao, Xiang
Zhang, Hu
Su, Jingling
Feng, Baisui
Zhao, Ye
Zhu, Liangru
Chen, Yan
Zhu, Lanxiang
Chen, Chunxiao
Wang, Yali
Wang, Yingde
Pang, Zhi
Chen, Yingxuan
Zhang, Xiaolan
Li, Hui
Yu, Qin
Ye, Mei
Zhang, Sumin
Tang, Wen
Wang, Mei
Cao, Xiaocang
Zhu, Ruixin
Zhou, Guangxi
Bian, Zhaolian
Guo, Xiaofeng
Wu, Xiaoli
Liu, Jinchun
Xu, Wei
Li, Yuqin
Guo, Qin
Guo, Zhiguo
Zhu, Shu https://orcid.org/0000-0002-8163-0869
Li, Dalin https://orcid.org/0000-0003-4738-0074
Liu, Jianjun https://orcid.org/0000-0002-3255-3019
Ge, Tian
Cho, Judy https://orcid.org/0000-0002-7959-0466
Daly, Mark J.
McGovern, Dermot P. B.
Ye, Byong Duk https://orcid.org/0000-0001-6647-6325
Song, Kyuyoung https://orcid.org/0000-0003-3067-0139
Kakuta, Yoichi https://orcid.org/0000-0002-7042-009X
Li, Mingsong https://orcid.org/0000-0003-2115-5928
Huang, Hailiang https://orcid.org/0000-0003-1461-5762
- License Information
-
More Information
Article History
Received: 14 June 2022
Accepted: 27 March 2023
First Online: 8 May 2023
Competing interests
: W.S. and C.S. are employees of Digital Health China Technologies Corp. Ltd. M.J.D. is a founder of Maze Therapeutics. D.P.B.M. has received consultancy fees from Prometheus Biosciences, Prometheus Laboratories, Takeda, Gilead, Pfizer. Stock—Prometheus Biosciences. B.D.Y. has served on advisory boards for AbbVie Korea, Celltrion, Daewoong Pharma, Ferring Korea, Janssen Korea, Pfizer Korea and Takeda Korea; has received research grants from Celltrion and Pfizer Korea; has received consulting fees from Chong Kun Dang Pharm., CJ Red BIO, Cornerstones Health, Daewoong Pharma, IQVIA, Kangstem Biotech, Korea United Pharm. Inc., Medtronic Korea, NanoEntek and Takeda; and has received speaking fees from AbbVie Korea, Celltrion, Ferring Korea, IQVIA, Janssen Korea, Pfizer Korea, Takeda and Takeda Korea. H.H. received consultancy fees from Ono Pharmaceutical and an honorarium from Xian Janssen Pharmaceutical. The remaining authors declare no competing interests.
